These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 30216159)

  • 1. How a 'Waste-Free Formulary' Misses What's Most Important to Employers.
    Bright J; Linthicum M
    Manag Care; 2018 Sep; 27(9):30. PubMed ID: 30216159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Few. The Effective. The Cheapest. The Waste-Free Formulary.
    Burns J
    Manag Care; 2018 Aug; 27(8):17-18. PubMed ID: 30142058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of health-related quality of life information in managed care formulary decision-making.
    Wu WK; Sause RB; Zacker C
    Res Social Adm Pharm; 2005 Dec; 1(4):579-98. PubMed ID: 17138497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
    Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicine and the pharmaceutical industry: what's right, what's wrong, and what's to come.
    Tan SY
    Singapore Med J; 1998 Mar; 39(3):91-5. PubMed ID: 9632964
    [No Abstract]   [Full Text] [Related]  

  • 7. Validating a hospital medicines formulary survey in the Western Pacific Region--a global hospital pharmacy initiative based on the Basel Statements.
    Penm J; Chaar B; Moles R
    Res Social Adm Pharm; 2012; 8(4):298-308. PubMed ID: 22169173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do employers voluntarily include patient protections in self-insured managed care plans?
    Lawlor JS; Hall MA
    Manag Care Interface; 2005 Jan; 18(1):76-80. PubMed ID: 15682634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formularies in integrated health systems: Fallon Healthcare System.
    Cano SB
    Am J Health Syst Pharm; 1996 Feb; 53(3):270-3. PubMed ID: 8808021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug formularies--good or evil? A view from a managed care provider.
    Giaquinta D
    Cardiology; 1994; 85 Suppl 1():30-5. PubMed ID: 7743532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of incentive-based formularies on prescription-drug utilization and spending.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Frank RG
    N Engl J Med; 2003 Dec; 349(23):2224-32. PubMed ID: 14657430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulary: what it is and how it works.
    Smith G
    J Healthc Resour Manag; 1996 Sep; 14(7):11-3. PubMed ID: 10161584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug formularies: myths-in-formation.
    Rucker TD; Schiff G
    Med Care; 1990 Oct; 28(10):928-42. PubMed ID: 2232923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors.
    Wang YR; Pauly MV
    Manag Care Interface; 2005 Aug; 18(8):39-45. PubMed ID: 16127891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of limited lists and formularies: are they cost-effective?
    Pearce MJ; Begg EJ
    Pharmacoeconomics; 1992 Mar; 1(3):191-202. PubMed ID: 10147029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small employers and self-insured health benefits: too small to succeed?
    Yee T; Christianson JB; Ginsburg PB
    Issue Brief Cent Stud Health Syst Change; 2012 Jul; (138):1-4. PubMed ID: 22812029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in managed care drug formularies: what can consumers learn?
    Schweitzer SO
    Med Care Res Rev; 2000 Sep; 57(3):326-39. PubMed ID: 10981188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do drug formulary policies reflect evidence of value?
    Neumann PJ; Lin PJ; Greenberg D; Berger M; Teutsch S; Mansley E; Weinstein MC; Rosen AB
    Am J Manag Care; 2006 Jan; 12(1):30-6. PubMed ID: 16402886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician satisfaction with formulary policies: is it access to formulary or nonformulary drugs that matters most?
    Glassman PA; Good CB; Kelley ME; Bradley M; Valentino M
    Am J Manag Care; 2004 Mar; 10(3):209-16. PubMed ID: 15032258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting formulary pull-through strategies: the role of pharmaceutical manufacturers.
    Navarro RP
    Manag Care Interface; 1999 May; 12(5):84-6. PubMed ID: 10537482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.